Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure☆
References (27)
- et al.
Hemodynamic effect of salbutamol, an oral long-acting beta-stimulant in patients with congestive heart failure
Am Heart J
(1982) New hope for the failing heart
Am J Med
(1982)Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticism
J Am Coll Cardiol
(1983)- et al.
Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy
Am J Cardiol
(1983) - et al.
Acute and follow-up studies with pirbuterol in heart failure (abstr)
Am J Cardiol
(1981) - et al.
Therapeutic efficacy of oral pirbuterol in severe chronic congestive heart failure: Acute hemodynamic and long-term ambulatory evaluation
Am Heart J
(1981) - et al.
Long-term therapy of heart failure with prazosin: A randomized double blind trial
Am J Cardiol
(1980) - et al.
Hydralazine in long-term treatment of chronic heart failure: Lack of difference from placebo
Am Heart J
(1982) - et al.
Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure
Am J Cardiol
(1979) - et al.
Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy
Circulation
(1978)
Hemodynamic effects of oral salbutamol in patients with severe LV failure (abstr)
Circulation
(1979)
Salbutamol in treatment of heart failure
Br Heart J
(1980)
Hemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe CHF
Br Heart J
(1980)
Cited by (59)
Heart failure and chronic obstructive pulmonary disease: The quandary of beta-blockers and beta-agonists
2011, Journal of the American College of CardiologyShould acute treatment with inhaled beta agonists be withheld from patients with dyspnea who may have heart failure?
2011, Journal of Emergency MedicineCitation Excerpt :Fifteen studies with 230 patients reported on the occurrence of dysrhythmias (8–10,13–15,18–20,22–24,26,29). Six of these studies reported an increase in ventricular ectopy, with one reported episode of supraventricular tachycardia, and 4 patients with treatment-induced non-sustained ventricular tachycardia (8,20,22,24,29,30). No patient required treatment to terminate the dysrhythmia and all resolved with discontinuation of albuterol.
Cardiac cachexia: A systematic overview
2009, Pharmacology and TherapeuticsThe effect of salbutamol on skeletal muscle in chronic heart failure
2000, International Journal of Cardiologyβ<inf>2</inf>-Adrenoceptors and ventricular fibrillation
2000, Pharmacology and Therapeutics
- ☆
Supported by the Department of Medicine of the Montreal General Hospital, and the Québec Heart Foundation.
Copyright © 1985 Published by Mosby, Inc.